Cardiogenic Shock
Symptoms, Doctors, Treatments, Advances & More

Learn About Cardiogenic Shock

What is the definition of Cardiogenic Shock?

Cardiogenic shock takes place when the heart is unable to supply enough blood and oxygen to the organs of the body.

What are the alternative names for Cardiogenic Shock?

Shock - cardiogenic

What are the causes of Cardiogenic Shock?

The most common causes of cardiogenic shock are serious heart conditions. Many of these occur during or after a heart attack (myocardial infarction). These complications include:

  • A large section of heart muscle that no longer moves well or does not move at all
  • Breaking open (rupture) of the heart muscle due to damage from the heart attack
  • Dangerous heart rhythms, such as ventricular tachycardia, ventricular fibrillation, or supraventricular tachycardia
  • Pressure on the heart due to a buildup of fluid around it (pericardial tamponade)
  • Tear or rupture of the muscles or tendons that support the heart valves, especially the mitral valve
  • Tear or rupture of the wall (septum) between the left and right ventricles (lower heart chambers)
  • Very slow heart rhythm (bradycardia) or problem with the electrical system of the heart (heart block)

Cardiogenic shock occurs when the heart is unable to supply as much blood as the body needs. It can happen even if there hasn't been a heart attack. For example, if one of these problems listed above occurs and your heart function drops suddenly. Or if a valve becomes obstructed or if a combination of problems occurs.

What are the symptoms of Cardiogenic Shock?

Symptoms include:

  • Chest pain or pressure
  • Coma
  • Decreased urination
  • Fast breathing
  • Fast pulse
  • Heavy sweating, moist skin
  • Lightheadedness
  • Loss of alertness and ability to concentrate
  • Restlessness, agitation, confusion
  • Shortness of breath
  • Skin that feels cool to the touch
  • Pale skin color or blotchy skin
  • Weak (thready) pulse
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Cardiogenic Shock?

Cardiogenic shock is a medical emergency. You will need to stay in the hospital, most often in the Intensive or Coronary Care Unit (ICU). The goal of treatment is to find and treat the cause of shock to save your life.

You may need medicines to increase blood pressure and improve heart function, including:

  • Dobutamine
  • Dopamine
  • Epinephrine
  • Levosimendan
  • Milrinone
  • Norepinephrine
  • Vasopressin

These medicines may help in the short-term. They are not often used for a long time.

When a heart rhythm disturbance (dysrhythmia) is serious, urgent treatment may be needed to restore a normal heart rhythm. This may include:

  • Electrical "shock" therapy (defibrillation or cardioversion)
  • Implanting a temporary pacemaker
  • Medicines given through a vein (IV)

You may also receive:

  • Pain medicine
  • Oxygen
  • Fluids, blood, and blood products through a vein (IV)

Other treatments for shock may include:

  • Cardiac catheterization with coronary angioplasty and stenting
  • Heart monitoring to guide treatment
  • Heart surgery (coronary artery bypass surgery, heart valve replacement, left ventricular assist device)
  • Intra-aortic balloon counterpulsation (IABP) to help the heart work better
  • Pacemaker
  • Ventricular assist device or other mechanical support
Who are the top Cardiogenic Shock Local Doctors?
Maya E. Guglin
Elite in Cardiogenic Shock
Cardiology | Transplant Surgery | Advanced Heart Failure and Transplant Cardiology
Elite in Cardiogenic Shock
Cardiology | Transplant Surgery | Advanced Heart Failure and Transplant Cardiology

Rutgers Health-Rwj Scleroderma Program

10 Plum St, 
New Brunswick, NJ 
Languages Spoken:
English, Russian
Accepting New Patients

Maya Guglin is a Cardiologist and a Transplant Surgeon in New Brunswick, New Jersey. Dr. Guglin is rated as an Elite provider by MediFind in the treatment of Cardiogenic Shock. Her top areas of expertise are Heart Failure, Cardiogenic Shock, Cardiomyopathy, Heart Transplant, and Lung Transplant. Dr. Guglin is currently accepting new patients.

Maryjane A. Farr
Elite in Cardiogenic Shock
Advanced Heart Failure and Transplant Cardiology | Cardiology
Elite in Cardiogenic Shock
Advanced Heart Failure and Transplant Cardiology | Cardiology

University Of Texas Southwestern Medical Center At Dallas

5939 Harry Hines Blvd, 
Dallas, TX 
Languages Spoken:
English

Maryjane Farr is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Dallas, Texas. Dr. Farr is rated as an Elite provider by MediFind in the treatment of Cardiogenic Shock. Her top areas of expertise are Heart Failure, Cardiogenic Shock, Cardiomyopathy, Pulmonary Edema, and Heart Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Navin Kapur
Elite in Cardiogenic Shock
Cardiology
Elite in Cardiogenic Shock
Cardiology

Tufts Medical Center Cardiology

860 Washington St Bldg 6, 
Boston, MA 
Languages Spoken:
English

Navin Kapur is a Cardiologist in Boston, Massachusetts. Dr. Kapur is rated as an Elite provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Cardiogenic Shock, Heart Attack, Heart Failure, Heart Transplant, and Percutaneous Coronary Intervention (PCI).

What is the outlook (prognosis) for Cardiogenic Shock?

In the past, the death rate from cardiogenic shock ranged from 80% to 90%. In more recent studies, this rate has decreased to 50% to 75%.

When cardiogenic shock is not treated, the outlook is very poor.

What are the possible complications of Cardiogenic Shock?

Complications may include:

  • Brain damage
  • Kidney damage
  • Liver damage
When should I contact a medical professional for Cardiogenic Shock?

Go to the emergency room or call 911 or the local emergency number if you have symptoms of cardiogenic shock. Cardiogenic shock is a medical emergency.

How do I prevent Cardiogenic Shock?

You may reduce the risk for developing cardiogenic shock by:

  • Quickly treating its cause (such as heart attack or heart valve problem)
  • Preventing and treating the risk factors for heart disease, such as diabetes, high blood pressure, high cholesterol and triglycerides, or tobacco use
What are the latest Cardiogenic Shock Clinical Trials?
Arterial Compliance as a Predictor of Clinical Outcomes With Intra-aortic Balloon Counterpulsation: A Prospective Observational Pilot Study

Summary: The investigators intend to study how baseline arterial compliance (as defined by stroke volume/pulse pressure) influences the clinical success of intraaortic balloon counterpulsation (IABC) in patients with cardiogenic shock (CS). The investigators aim to compare clinical outcomes in CS patients requiring IABC with normal compliance versus low compliance. The study will enroll patients undergoing...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Clinical Feasibility Study of the Magenta Elevate™ Percutaneous Left Ventricular Assist Device (pLVAD) System in Patients With Cardiogenic Shock

Summary: The Elevate™ CS Clinical Feasibility Study is designed to evaluate the initial safety, effectiveness, and device performance of the Magenta Elevate™ System in patients with cardiogenic shock due to isolated or predominant left ventricular failure.

Who are the sources who wrote this article ?

Published Date: May 27, 2024
Published By: Michael A. Chen, MD, PhD, Associate Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, WA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Felker GM, Teerlink JR. Diagnosis and management of acute heart failure. In: Libby P, Bonow RO, Mann DL, Tomaselli GF, Bhatt DL, Solomon SD, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 12th ed. Philadelphia, PA: Elsevier; 2022:chap 49.

McMurray JJV, Pfeffer MA. Heart failure: treatment and prognosis. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024: chap 46.

Rogers JG, O'Connor CM. Heart failure: epidemiology, pathobiology, and diagnosis. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024: chap 45.